Molecular Targets for Biological Therapies of Severe Asthma: Focus on Benralizumab and Tezepelumab

Asthma is a heterogeneous respiratory disease characterized by usually reversible bronchial obstruction, which is clinically expressed by different phenotypes driven by complex pathobiological mechanisms (endotypes). In recent years several molecular effectors and signaling pathways have emerged as...

Descripción completa

Detalles Bibliográficos
Autor principal: Cheng, Shih-Lung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399988/
https://www.ncbi.nlm.nih.gov/pubmed/34440488
http://dx.doi.org/10.3390/life11080744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399988/
https://www.ncbi.nlm.nih.gov/pubmed/34440488
http://dx.doi.org/10.3390/life11080744

Ejemplares similares